Financials data is unavailable for this security.
View more
Year on year Cryo-Cell International Inc had net income fall from a gain of 2.77m to a loss of 9.52m despite a 3.32% increase in revenues from 30.34m to 31.34m. An increase in the selling, general and administrative costs as a percentage of sales from 51.36% to 54.61% was a component in the falling net income despite rising revenues.
| Gross margin | 73.66% |
|---|---|
| Net profit margin | -28.04% |
| Operating margin | -39.49% |
| Return on assets | -13.45% |
|---|---|
| Return on equity | -- |
| Return on investment | -18.45% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Cryo-Cell International Inc fell by 1.30m. However, the company earned 8.92m from its operations for a Cash Flow Margin of 28.46%. In addition the company used 8.14m on investing activities and also paid 2.07m in financing cash flows.
| Cash flow per share | -0.9868 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -1.19 |
|---|---|
| Tangible book value per share | -1.54 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.6119 |
|---|---|
| Quick ratio | 0.5699 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -449.47%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -462.03 |
